Answers are grounded in this paper and cite their sources.
This exploratory pilot randomized controlled trial investigated whether a nocturnal pressurization intervention, designed to simulate altitude reduction during sleep, was associated with changes in multi-system physiological responses in male workers with chronic intermittent high-altitude exposure. Twenty-four male workers were randomized to a Pressurization group (n = 12) or a control group (n = 12); Over a 5-week protocol, the Pressurization group slept at the simulated altitudes while both groups worked at 3500 m. The primary outcome was mean nocturnal peripheral oxygen saturation (SpO 2 ); secondary outcomes were ambulatory blood pressure (BP), serum normetanephrine and metanephrine, Renin–Angiotensin–Aldosterone System components, and oxidative stress markers. The intervention was associated with short-term changes, the largest of which occurred during the 2000 m-simulated week. SpO 2 was higher than in controls at 2500 m and 2000 m (both p < 0.001). Nocturnal diastolic BP was lower at 2500 m (− 7.25 mmHg, p = 0.024), normetanephrine, metanephrine and angiotensin II were reduced at 2000 m (Ang II: −23.10 pg/mL, p = 0.011), and 8-iso-PGF2α was lower with higher total antioxidant capacity at both altitudes. None of these differences persisted at the fifth-week recovery assessment. A nocturnal pressurization intervention simulating descent to 2000 m was associated with improved nocturnal oxygenation and short-term reductions in neurohormonal and oxidative stress in male high-altitude workers. The changes were reversible and had disappeared one week after the intervention ceased; they should therefore not be interpreted as an improvement in long-term adaptation, and the study should be regarded as hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: